Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Functiona
- 1 June 1993
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 681 (1) , 529-538
- https://doi.org/10.1111/j.1749-6632.1993.tb22936.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Seronegative myasthenia gravis: A plasma factor inhibiting agonist‐induced acetylcholine receptor function copurifies with IgMAnnals of Neurology, 1991
- A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in ‘antibody-negative’ myasthenia gravisJournal of Neuroimmunology, 1990
- Immunological and pharmacological heterogeneity of α-bungarotoxin binding sites extracted from TE671 cellsJournal of Neuroimmunology, 1988
- Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell lineJournal of Neuroimmunology, 1988
- MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITYThe Lancet, 1986
- Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Measurement of junctional acetylcholine receptors in myasthenia gravis: Clinical correlatesMuscle & Nerve, 1985
- Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- ACETYLCHOLINE RECEPTORS AND END-PLATE ELECTROPHYSIOLOGY IN MYASTHENIA GRAVISBrain, 1978
- Myasthenia GravisNew England Journal of Medicine, 1977